Allogeneic Anti-Bcma CAR-T Cells Show Tumour Specific Killing Against Primary Multiple Myeloma Cells from Different Genomic Sub-Groups
Ana M. Metelo(London Cancer), Reuben Benjamin(King's College London), Cesar Sommer(Allogene Therapeutics (United States)), Barbra J. Sasu(Unknown), Kirsty Cuthill, Katy Sanchez(King's College Hospital), Charlotte Attwood(London Cancer), Agnieszka Jóźwik(King's College Hospital NHS Foundation Trust), Matthew Streetly(King's College - North Carolina), Alan Dunlop(King's College Hospital), Trevor Bentley(Allogene Therapeutics (United States)), Charlotte Graham(Broad Institute), Ieuan Walker(King's College London), Carmel Rice(King's College Hospital NHS Foundation Trust), Bijan Boldajipour(University of Münster)
Cited by 3
Related Papers
Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette
|Stem Cells|2008|677
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421